(Q39485472)

12 September 2017

Resection for hilar cholangiocarcinoma: analysis of prognostic factors and the impact of systemic inflammation on long-term outcome (English)

1 reference

12 September 2017

0 references

0 references

systemic inflammation

1 reference

Traian Dumitrascu

1

1 reference

12 September 2017

Dragos Chirita

series ordinal

2

1 reference

12 September 2017

Mihnea Ionescu

series ordinal

3

1 reference

12 September 2017

Irinel Popescu

series ordinal

4

1 reference

12 September 2017

15 January 2013

1 reference

Journal of Gastrointestinal Surgery

12 September 2017

1 reference

12 September 2017

17

1 reference

12 September 2017

5

1 reference

12 September 2017

913-924

1 reference

https://scigraph.springernature.com/pub.10.1007/s11605-013-2144-2

12 September 2017

0 references

cites work

Surgical management of proximal bile duct cancers

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2144-2

Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2144-2

Surgery for hilar cholangiocarcinoma: French experience in a collective survey of 552 extrahepatic bile duct cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2144-2

Multidisciplinary management of hilar cholangiocarcinoma (Klatskin tumor): extended resection is associated with improved survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2144-2

Role of systemic inflammatory response in predicting survival in patients with primary operable cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2144-2

Impact of systemic inflammation on outcome following resection for intrahepatic cholangiocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2144-2

Prognosis of resected ampullary adenocarcinoma by preoperative serum CA19-9 levels and platelet-lymphocyte ratio.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2144-2

Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2144-2

Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2144-2

Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2144-2

Post-hepatectomy haemorrhage: a definition and grading by the International Study Group of Liver Surgery (ISGLS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2144-2

Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2144-2

Surgical treatment of hilar cholangiocarcinoma in the "new era": the Nagoya University experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2144-2

Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins: results of a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2144-2

Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2144-2

Extent of liver resection for hilar cholangiocarcinoma (Klatskin tumor): how much is enough?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2144-2

Surgical management of proximal bile duct cancer: extended right lobe resection increases resectability and radicality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2144-2

The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2144-2

Prognostic significance of lymph node ratio after resection of peri-hilar cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2144-2

Surgical resection of hilar cholangiocarcinoma: analysis of survival and postoperative complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2144-2

Management of hilar cholangiocarcinoma: comparison of an American and a Japanese experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2144-2

Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2144-2

Preoperative biliary drainage before resection for cholangiocarcinoma (Pro).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2144-2

Endoscopic and percutaneous preoperative biliary drainage in patients with suspected hilar cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2144-2

Cholangiocarcinoma: preoperative biliary drainage (Con).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2144-2

Post-operative morbidity results in decreased long-term survival after resection for hilar cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2144-2

Gemcitabine-based adjuvant chemotherapy improves survival after aggressive surgery for hilar cholangiocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2144-2

One hundred consecutive hepatobiliary resections for biliary hilar malignancy: preoperative blood donation, blood loss, transfusion, and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2144-2

Resectional surgery of hilar cholangiocarcinoma: a multivariate analysis of prognostic factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2144-2

Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2144-2

A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2144-2

Inflammation-induced protein carbonylation contributes to poor prognosis for cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2144-2

Sulindac prevents carcinogen-induced intrahepatic cholangiocarcinoma formation in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2144-2

C-reactive protein is a prognostic indicator in patients with perihilar cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2144-2

Proximal bile duct cancer: high resectability rate and 5-year survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2144-2

The Blumgart Preoperative Staging System for Hilar Cholangiocarcinoma: Analysis of Resectability and Outcomes in 380 Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2144-2

Papillary phenotype confers improved survival after resection of hilar cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2144-2

Molecular pathogenesis of cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-013-2144-2

Disease recurrence patterns after R0 resection of hilar cholangiocarcinoma

21 January 2018

1 reference

12 December 2020

Predictive factors for prognosis of hilar cholangiocarcinoma: postresection radiotherapy improves survival

1 reference

12 December 2020

Improved outcome of resection of hilar cholangiocarcinoma (Klatskin tumor)

1 reference

12 December 2020

Preoperative Neutrophil-to-Lymphocyte Ratio (NLR) is Associated with Reduced Disease-free Survival Following Curative Resection of Pancreatic Adenocarcinoma

1 reference

12 December 2020

Combined vascular resection in operative resection for hilar cholangiocarcinoma: does it work or not?

1 reference

12 December 2020

Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer

1 reference

12 December 2020

Oncological superiority of hilar en bloc resection for the treatment of hilar cholangiocarcinoma

1 reference

12 December 2020

Major hepatectomy for hilar cholangiocarcinoma type 3 and 4: prognostic factors and longterm outcomes

1 reference

12 December 2020

Preoperative cholangitis independently increases in-hospital mortality after combined major hepatic and bile duct resection for hilar cholangiocarcinoma

1 reference

12 December 2020

Surgery for hilar cholangiocarcinoma: a multi-institutional update on practice and outcome by the AFC-HC study group

1 reference

12 December 2020

Improved outcomes after aggressive surgical resection of hilar cholangiocarcinoma: a critical analysis of recurrence and survival

1 reference

12 December 2020

Neoadjuvant therapy and liver transplantation for hilar cholangiocarcinoma: is pretreatment pathological confirmation of diagnosis necessary?

1 reference

12 December 2020

The association of pre-treatment peripheral blood markers with survival in patients with pancreatic cancer.

1 reference

12 December 2020

Caudate lobe resection with major hepatectomy for central cholangiocarcinoma: is it of value?

1 reference

12 December 2020

Outcome of surgical treatment of hilar cholangiocarcinoma: a special reference to postoperative morbidity and mortality

1 reference

12 December 2020

Improvement in perioperative and long-term outcome after surgical treatment of hilar cholangiocarcinoma: results of an Italian multicenter analysis of 440 patients

1 reference

12 December 2020

Surgical treatment of hilar cholangiocarcinoma in a new era: comparison among leading Eastern and Western centers, Leeds

1 reference

12 December 2020

Interleukin-6 and its receptor, key players in hepatobiliary inflammation and cancer

1 reference

12 December 2020

Analysis of the surgical outcome and prognostic factors for hilar cholangiocarcinoma: a Chinese experience

1 reference

12 December 2020

Role of caudate lobectomy in type III A and III B hilar cholangiocarcinoma: a 15-year experience in a tertiary institution

1 reference

12 December 2020

10.1007/S11605-013-2144-2

Identifiers

DOI

1 reference

12 September 2017

1 reference